- Nachrichtendetail
-
18.06.2024 14:05:04 - dpa-AFX: *LIGAND SAYS MERCK RECEIVES FDA APPROVAL FOR PNEUMOCOCCAL 21-VALENT CONJUGATE VACCINE FOR ADULTS
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
Merck & Co | A0YD8Q | NYSE | 126,730 | 28.06.24 21:54:51 | -3,090 | -2,38% | 126,710 | 126,740 | 131,990 | 129,820 |
|
Ligand Pharmaceuticals | A1C9RN | NASDAQ | 83,955 | 28.06.24 21:54:43 | +1,625 | +1,97% | 83,850 | 84,320 | 82,720 | 82,330 |
